Your browser doesn't support javascript.
loading
The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition.
Sakai, Takehiko; Kutomi, Goro; Shien, Tadahiko; Asaga, Sota; Aruga, Tomoyuki; Ishitobi, Makoto; Kuba, Sayaka; Sawaki, Masataka; Terata, Kaori; Tomita, Koichi; Yamauchi, Chikako; Yamamoto, Yutaka; Iwata, Hiroji; Saji, Shigehira.
Affiliation
  • Sakai T; Department of Breast Surgical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. takehiko.sakai@jfcr.or.jp.
  • Kutomi G; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan.
  • Shien T; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
  • Asaga S; Department of Breast Surgery, Keiyu Hospital, Yokohama, Japan.
  • Aruga T; Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Ishitobi M; Department of Breast Surgery, Mie University School of Medicine, Mie, Japan.
  • Kuba S; Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
  • Terata K; Department of Breast and Endocrine Surgery, Akita University Hospital, Akita, Japan.
  • Tomita K; Department of Plastic and Reconstructive Surgery, Kindai University, Osaka, Japan.
  • Yamauchi C; Department of Radiation Oncology, Shiga General Hospital, Shiga, Japan.
  • Yamamoto Y; Department of Breast and Endocrine Surgery, Kumamoto University Hospital, Kumamoto, Japan.
  • Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
  • Saji S; Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan.
Breast Cancer ; 31(1): 1-7, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37843765
ABSTRACT
The 2022 revision of the Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for surgical treatment of breast cancer was updated following a systematic review of the literature using the Medical Information Network Distribution Service (MINDS) procedure, which focuses on the balance of benefits and harms for various clinical questions (CQs). Experts in surgery designated by the JBCS addressed five areas breast surgery, axillary surgery, breast reconstruction, surgical treatment for recurrent and metastatic breast cancer, and other related topics. The revision of the guidelines encompassed 4 CQs, 7 background questions (BQs), and 14 future research questions (FRQs). A significant revision in the 2022 edition pertained to axillary management after neoadjuvant chemotherapy in CQ2. The primary aim of the 2022 JBCS Clinical Practice Guidelines is to provide evidence-based recommendations to empower patients and healthcare professionals in making informed decisions regarding surgical treatment for breast cancer.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Country/Region as subject: Asia Language: En Journal: Breast Cancer Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Publication country: JAPAN / JAPON / JAPÃO / JP
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Country/Region as subject: Asia Language: En Journal: Breast Cancer Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Publication country: JAPAN / JAPON / JAPÃO / JP